Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penam Laboratories is an Indian pharmaceutical company specializing in the manufacture of Beta-lactam antibiotics, including Penicillins and Cephalosporins. Established in 1989, the company operates state-of-the-art manufacturing facilities that produce Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Their product portfolio includes widely used antibiotics such as Amoxicillin, Ampicillin, and Cloxacillin. Penam serves both domestic and international markets, providing high-quality generic medications and contract manufacturing services. The company is recognized for its adherence to international quality standards, including WHO-GMP certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penam Laboratories.